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Abstract
Background: Binding of two 9-O-(v-amino) alkyl ether berberine analogs BC1 and BC2 to the RNA triplex
poly(U)Npoly(A)*poly(U) was studied by various biophysical techniques.
Methodology/Principal Findings: Berberine analogs bind to the RNA triplex non-cooperatively. The affinity of binding was
remarkably high by about 5 and 15 times, respectively, for BC1 and BC2 compared to berberine. The site size for the binding
was around 4.3 for all. Based on ferrocyanide quenching, fluorescence polarization, quantum yield values and viscosity
results a strong intercalative binding of BC1 and BC2 to the RNA triplex has been demonstrated. BC1 and BC2 stabilized the
Hoogsteen base paired third strand by about 18.1 and 20.5uC compared to a 17.5uC stabilization by berberine. The binding
was entropy driven compared to the enthalpy driven binding of berbeine, most likely due to additional contacts within the
grooves of the triplex and disruption of the water structure by the alkyl side chain.
Conclusions/Significance: Remarkably higher binding affinity and stabilization effect of the RNA triplex by the amino alkyl
berberine analogs was achieved compared to berberine. The length of the alkyl side chain influence in the triplex
stabilization phenomena.
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Introduction
Triple helix formation has been proposed as a means for
sequence-specific recognition and binding by a relatively short
single stranded DNA or RNA to either a double-stranded DNA or
RNA [1–7] originally discovered by Rich and coworkers as early
as in 1957 [8]. The binding of the third strand on the duplex to
form the triplex occurs essentially by Hoogsteen base paired H-
bonding interactions in the major groove of the duplex. The
antiparallel arrangement of a purine strand flanked by two
pyrimidine strands is termed as the ‘pyrimidine-purine*pyrimidine’
(YRY, Y is pyrimidine and R is purine) motif that yields C.G*C
+,
T.A*T (DNA triplexes) or the U.A*U triplex (RNA triplex)
(symbols . and * represent Watson-Crick and Hoogsteen base
pairing strands of the triplex). Triplex nucleic acids may have
functional roles in many cellular processes such as transcriptional
regulation, post-transcriptional RNA processing, modification of
chromatin structure, DNA repair etc. For example, DNA triplex
formation may be involved the c-myc proto-oncogene regulation
[9] and RNA triplexes may exist within transfer RNA [10,11] the
Tetrahymena group I intron [12–14], the human immunodeficiency
virus TAR RNA [15–17] HIV frame shift signal etc [18]. The
discovery of the triplex-unwinding helicases [19] as well as the
recent revelation of the genomics and many critical biological roles
of the non-coding RNAs [20] necessitate the speculation of the
involvement of triple-helices in many critical roles in the cell [21–
24]. The potential in vivo roles and importance of nucleic acid
triple helical structures have been reviewed in great details recently
[25].
Due to Hoogsteen base pairing, stability of the triplex structure
is relatively lower compared to the corresponding duplex and the
third strand dissociates at a much lower temperature compared to
the duplex denaturation temperature. This is a critical limitation
in their utility and application in vivo as probes of structure,
inhibitors of protein synthesis as well as therapeutic agents.
Therefore, molecules having the ability to recognize, bind and
stabilize specific sequences of triple helical nucleic acid structures
are of particular interest in antigene therapy. Recently several
biophysical studies on the properties of DNA triple helices
[2,3,26,27] and many small molecules that can enhance the
stability of triplexes have been described [28–31]. But most of
these are limited to DNA triplexes and studies on the stabilization
of RNA triplexes and correlating thermodynamic factors to the
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in stability are scarce. Our laboratory has shown that many
isoquinoline alkaloids can bind and significantly stabilize RNA
triplexes [32].
Berberine is a natural alkaloid with remarkable biological
relevance and utility, and represents a potential molecule for drug
screening and development. The antiproliferative property and
sensitivity enhancement of berberine to various cancer cell lines
[33–39] have led to significant interest in this molecule as a
prospective anticancer drug candidate [40,41]. The potential
biotargets of berberine may include DNA topoisomerases,
telomerase, and DNA or RNA structures. In particular, DNA
and RNA have long been thought to be the target in manifesting
its anticancer activities, and accordingly, the binding properties to
single strands, duplex, triplex, and quadruplex structures have
been described in many recent publications and reviews [42–44].
Notably, these studies have revealed an unusually high affinity and
induction of self-structure formation by berberine to poly(A)
[45,46]. Currently, RNA molecules are thought to be involved in
many cellular activities and RNA triplex structures may be a
potential structural motif for therapeutic intervention.
In order to improve the efficacy of berberine and make it a
viable therapeutic agent many synthetic strategies have been
adopted recently [47–50]. Substitution on the isoquinoline moiety
has been an important approach and the enhanced effect of 9-
substituted analogs on drug-topoisomerase II interactions is well
documented several years ago [51]. The 9-substituent within the
domain has a major influence, presumably by facilitating drug
interaction with enzyme and/or enzyme-DNA complexes and
many were synthesized to enhance the DNA binding as well as
pharmacological activities [52–56]. In this manuscript we describe
the triplex-binding affinities and the associated thermodynamic
aspects of the interaction of two new 9-amino alkyl analogs
(Figure 1) in comparison to berberine. These functional substit-
uents depending on the number of CH2 group have been
documented to increase duplex DNA binding affinities and also
induce self-structure formation in poly(A) [46,57]. Thus, the
interaction studies on these berberine derivatives with structural
alteration at the 9-position may provide key insights into the
different aspects of association process of berberine with RNA. In
the light of remarkably strong affinity of these molecules to various
nucleic acid structures as mentioned above in this study we
investigated the structural aspects in conjunction with energetics of
the interaction of two representative analogs with the RNA triplex
poly(U)Npoly(A)*poly(U) (RNA triplex hereafter).
Materials and Methods
Biochemicals
Polynucleotide samples of double stranded poly(A) Npoly(U) and
single stranded poly(U) were obtained from Sigma-Aldrich
Corporation (St. Louis, MO, USA) and were used as received.
Berberine was obtained from Aldrich and its analogs were
prepared and characterized as described in [58].
Preparation of Stock Solutions
The RNA triplex was prepared as reported earlier [32].
Concentration was determined using molar extinction coefficients
(e) reported in the literature [59]. For this study two 9-amino alkyl
berberine analogs (Figure 1) with chain length of 3 and 6 CH2
groups were used. They were fairly soluble in aqueous buffers, and
hence their solutions were freshly prepared each day and kept
protected in the dark until use. The concentration of berberine
was determined by an e value of 22,500 M
21 cm
21 at 345 nm
and that of the 9-analogs using a common e value of
22,500 M
21 cm
21 at 345 nm. No deviation from Beer’s law was
observed for the alkaloids in the concentration range employed in
this study. All experiments were performed in 10 mM sodium
cacodylate buffer containing 25 mM NaCl, 0.1 mM Na2EDTA,
pH 7.0 (total [Na
+] =35 mM). Glass distilled deionized water and
analytical grade reagents were used for the preparation of the
buffer. All buffer solutions were filtered through Millipore filters
(Millipore India Pvt. Ltd., Bangalore, India) of 0.22 mm pore size
before use. The triplex structure was characterized by circular
dichroic spectral pattern and biphasic optical melting profile [59–
60].
Absorbance Spectroscopy
Spectrophotometric titration of alkaloid analogs with the triplex
was performed on a Jasco V660 double beam double monochro-
mator spectrophotometer (Jasco, Hachioji, Japan) at 2560.5uC
using the methodologies described previously [61,62]. Matched
quartz cuvettes of 1 cm path length were used. A typical titration
was carried out by keeping a fixed known concentration of the
triplex solution in the sample and reference cuvettes and adding
successively small aliquots of a known concentrated stock of the
alkaloid into the sample cuvette and equivalent amount of buffer
into the reference cuvette. After each addition, the system was
allowed to equilibrate for at least 5 min. before noting the
absorbance at the wavelength maximum (Amax) of the alkaloid and
the isosbestic point (Aiso). The data obtained from these titrations
were quantified by constructing Scatchard plots [63].
Fluorescence Spectroscopy
Fluorescence titrations were performed on either a Shimadzu
RFPC fluorimeter (Shimadzu Corporation, Kyoto, Japan) or
Hitachi F4010 unit (Hitachi, Tolyo, Japan) in fluorescence free
quartz cuvettes of 1 cm path length in sample holder thermo
regulated at 2560.5uC using an Eyela Uni Cool U55 water bath
(Tokyo Rikakikai Co. Ltd. Tokyo, Japan). The uncorrected
emission spectra of the alkaloid and analogs were at first recorded
and then titrated with aliquots of triplex solution of high
concentration to prevent dilution effects. The samples were
excited at 350 nm and all the measurements were performed
under conditions of stirring.
Evaluation of Binding Affinity from Spectroscopic Results
In absorption spectroscopy, following each addition of the
alkaloid to the RNA triplex solution (50 mM), the total alkaloid
concentration (Ct) present was calculated as Ct~
Aiso
eiso
from the
absorbance at the respective isosbestic point (Aiso) where eiso is the
molar extinction coefficient at the isosbestic point. The expected
absorbance (Aexp) at the wavelength maximum was calculated
using the relation Aexp~Ctemax where emax is the molar extinction
coefficient at the wavelength maximum. The difference in Aexp
and the observed absorbance (Aobsd) was then used to calculate the
amount of bound alkaloid as Cb~ A
De~
Aexp{Aobsd
ef{eb
. The
concentration of the free alkaloid was determined by the
difference, Cf~Ct{Cb. The extinction coefficient of the com-
pletely bound alkaloid was determined by mixing a large excess of
the RNA triplex to a known quantities of the alkaloids assuming
total binding, eb~
Amax
Ct
. From the fluorescence data, Cb was
calculated using the relation Cb~
Ct(I{I0)
(V0{1)I0
, where Ct is the total
alkaloid concentration, I is the observed fluorescence intensity, Io
is the fluorescence intensity of identical concentration of the
Alkaloid Analog Triplex RNA Interaction
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determined ratio of the fluorescence intensity of totally bound
alkaloid to that of the free alkaloid. Free alkaloid concentrations
(Cf) were obtained from the relationshipCt~CbzCf. The binding
ratio r is defined as r~
Cb
½triplex total
.
These data were cast into Scatchard plots of r/Cf versus r. The
binding isotherms with negative slopes at low r values were
analyzed according to the excluded site model for a non-linear
non-cooperative ligand binding system using the following
equation
r
Cf
~Ki(1{nr)½
(1{nr)
f1{(n{1)rg
 
(n{1) ð1Þ
where Ki is the intrinsic binding constant to an isolated binding
site, and n is the number of nucleotides excluded by the binding of
a single alkaloid molecule. All the binding data were analyzed
using Origin 7.0 software (Microcal Inc., Northampton, MA,
USA) to determine the best-fit parameters of Ki and n as described
in details earlier [64].
Optical Thermal Melting Experiments
Optical thermal melting of the triplex and triplex-alkaloid
complexes was monitored by UV absorption at 260 nm and was
performed using a Shimadzu Pharmaspec 1700 unit equipped
with a peltier controlled TMSPC–model accessory (Shimadzu
Corporation, Kyoto, Japan) monitoring the absorbance change at
260 nm as described earlier [65,66]. The temperature of the
sample was increased at a rate of 1.0uC /min, typically starting at
20uC and ending at 70uC when both transitions were completed.
Measurement of Energy Transfer
Energy transfer from the triplex to the bound alkaloid was
measured from the excitation spectra of the complex in the
wavelength range 220–310 nm [67–69]. Excitation spectra were
recorded at an emission wavelength of 520 nm for BC and
analogs. The ratio Q~
qb
qf
, where qb and qf are the quantum
efficiencies of bound and free alkaloid, respectively, was calculated
for each wavelength using the equation Q~
qb
qf
~
Ibef
Ifeb
where Ib
and If are the fluorescence intensities of the alkaloids in the
presence and absence of the triplex, respectively, and eb and ef are
the corresponding alkaloid molar extinction coefficients. A plot of
the ratio, Ql/Q310 against wavelength was constructed. The
wavelength of 310 nm was chosen as the normalization wave-
length due to the negligible absorbance for triplex at this
wavelength.
Fluorescence Polarization Anisotropy Measurements
Fluorescence polarization anisotropy measurements of alkaloids
and triplex complexes were executed on a Hitachi F4010
fluorimeter (Hitachi Ltd. Tokyo, Japan) at 25
o. Steady state
polarization anisotropy ‘A’ is defined as
A~
(Ivv{IvhG)
(Ivvz2IvhG)
ð2Þ
where G is the ratio Ihv/Ihh used for instrumental correction. Ivv,
Ivh,I hv and Ihh represent the fluorescence signal for excitation and
emission with the polarizer positions set at (0u,0 u), (0u,9 0 u), (90u,
0u) and (90u,9 0 u), respectively.
Fluorescence Quenching Experiments
Fluorescence quenching experiments were performed by
mixing, in different ratios, two solutions, viz. KCl and
K4[Fe(CN6], at a fixed total ionic strength. At a constant P/D
(RNA triplex/alkaloid molar ratio) fluorescence intensity was
monitored as a function of varying concentration of the
ferrocyanide as described previously [32,70,71]. The data were
plotted as Stern-Volmer plots of relative fluorescence intensity (Fo/
F) versus [Fe(CN6]
42 concentration according to the Stern-
Volmer equation,
F0
F ~1zKsv½Q , where Fo and F denote the
fluorescence emission intensities in the absence and presence of
[Fe(CN6]
42 and [Q] is the quencher concentration. KSV is the
Stern-Volmer quenching constant, which gives an estimate of the
efficiency of quenching by the quencher.
Figure 1. Chemical structures of BC, analogs and the base triplet of poly(U)Npoly(A)*poly(U). (A) BC (B) BC analogs and (C) triplex.
doi:10.1371/journal.pone.0037939.g001
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A Cannon-Manning semi micro capillary viscometer (size 75,
Canon Instruments Co. State College, PA, USA) kept thermo-
stated at 2561.0uC was used to measure the time required for flow
to calculate the viscosity of the RNA triplex-alkaloid complexes.
Relative viscosities for RNA triplex either in presence or absence
of the alkaloids were calculated as reported earlier [72]. The re-
lative increase in length, L/Lo, may be obtained from the
corresponding increase in relative viscosity with the use of the
equation,
L
L0
~(
g
g0
)
1
3~1zbr, where L and Lo are the contour
lengths of triplex in presence and absence of the alkaloids, g and
go are the corresponding values of intrinsic viscosity (approximat-
ed by the reduced viscosity g~
gsp
C
, where C is the triplex
concentration). b is the slope of a plot of L/Lo versus r where a
slope of ,2 may suggest true intercalative binding.
Circular Dichroism Studies
Circular dichroism (CD) spectra were measured on a PC
controlled spectropolarimeter, JASCO J815 unit (Jasco, Hachioji,
Japan) equipped with a temperature programmer (model PFD
425L/15) at 2560.5
o. A rectangular strain free quartz cuvette of
1 cm path length was used. Each spectrum, averaged from four
successive accumulations at a scan rate of 100 nm/min. keeping a
bandwidth of 1.0 nm at a sensitivity of 100 milli degrees, was
baseline corrected, smoothed and normalized to nucleotide
phosphate concentration in the region 220–400 nm. The molar
ellipticity (h) values are expressed in deg. cm
2 dmol
21.
Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) was performed on a
MicroCal VP-ITC microcalorimeter (MicroCal, Inc., North-
ampton, MA, USA). Instrument control data acquisition, and
analysis were carried out using the in built Origin software 7.0
package using standard protocols reported earlier [66,70,73]. All
experiments were conducted at 25uC. Aliquots (10 mL) of the
alkaloid solution were injected from the rotating syringe
(286 r.p.m) into the isothermal sample chamber containing
1.4235 ml of the triplex solution (25 mM). Control experiments
to estimate the heat of dilution of the alkaloids were performed by
titrating the alkaloid solutions to the buffer kept in the calorimeter
cell under the same experimental conditions and protocols. Heat
of dilution of the triplex titration into buffer was found to be
negligible. Analysis of the integrated heat data was performed
using Origin 7.0.
Experimental data were fitted using a non-linear least-squares
minimization algorithm to a theoretical titration curve using
model of one site binding site Levenberg- Marquardt non-linear
least squares curve fitting algorithm equations included in the
software package of Origin 7.0 to estimate the binding affinity (Ka),
the binding stoichiometry (N) and the enthalpy of binding (DH
o).
The binding Gibbs energy (DG
o) and the entropic contribution
(TDS
o) to the binding were subsequently calculated from standard
relationships described earlier [65,73].
Results and Discussion
Electronic Absorption Spectral Studies of the Binding
The binding of the berberine analogs to the RNA triplex was at
first investigated by absorption spectral measurements. Berberine
and its analogs have characteristic visible absorption spectra with
intense peaks around 345 and 420 nms (Curve 1 of Fig. 2). As
aliquots of the triplex was added to the spectrophotometric cuvette
containing berberine and analogs, the intensity of the peaks
decreased with concomitant red shift of the peak maxima
generating sharp isosbestic points. Typical absorption spectral
changes for BC, BC1 and BC2 in presence of increasing
concentrations of the triplex are presented in Figure 2. Hypo-
chromic and bathochromic shifts of ligand centered transitions for
aromatic ligands typically arise from p-stacking interactions which
may result from intercalation with the base triplets. Berberine has
been revealed to intercalate between DNA bases from the recent
X-ray crystal structure data [43]. Similarly, berberine analogs
(Figure 1) should be able to intercalate between the base triplets
without large steric constraints and the alkyl side chain may
Figure 2. Absorption spectral change of alkaloids in presence
of triplex. (A) BC (B) BC1 (C) BC2 each of 5.0 mM treated with
increasing concentrations of poly(U)Npoly(A)*poly(U). P/D saturation for
BC, BC1 and BC2 were 28.0, 20.0 and 15.0, respectively. Inset: respective
non-cooperative Scatchard isotherms of the binding.
doi:10.1371/journal.pone.0037939.g002
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functional groups on the base triplets. The presence of clear
isosbestic points suggest that the alkaloid analogs bind to triplex by
equilibrium enabling the estimation of the binding affinity by
Scatchard analysis in comparison to BC. A summary of the optical
properties of free and poly(U).poly(A)*poly(U) bound alkaloid
analogs are presented in Table S1.
Spectrofluorimetric Studies
Berberine and its 9-amino alkyl analogs are weak fluorophores
with low fluorescence emission intensity that enhanced several-fold
on binding to nucleic acids [46,47]. In the presence of the triplex,
the intrinsic fluorescence of the analogs registered remarkably
large enhancement of the fluorescence intensity reaching a
saturation that can be used to evaluate the binding affinities.
The large enhancements may also be in support of the
hydrophobic position of the bound molecules between the base
triplets. Typical fluorescence spectral changes of BC, BC1 and
BC2 in presence of the RNA triplex are presented in Figure 3.
Evaluation of the Binding Affinities from Absorbance and
Fluorescence Titration Data
The spectral changes in the absorption and fluorescence
titration data were expressed as Scatchard plots and they are
depicted in the inset of Fig. 2 and 3. The Scatchard plots had
negative slopes at low r values enabling further analysis of the
curved isotherms by the McGhee-von Hippel methodology [74]
for non-cooperative binding for evaluation of the binding
constants and the number of excluded sites on binding of a single
alkaloid molecule. From this analysis, it was found that the binding
affinity values (Ki) of BC, BC1 and BC2 to the triplex were
2.8860.02610
5 M
21, 8.6560.34610
5 M
21, and
3.8760.41610
6 M
21, respectively, from absorption spectra. The
number of excluded sites was around 4.2, 4.2 and 4.3, respectively,
for BC, BC1 and BC2. Similarly spectrofluorimetric analysis of the
binding resulted in values with magnitudes close to that obtained
from absorption spectroscopy and these are presented in Table 1.
It can be seen that the binding affinity BC1 and BC2 to the RNA
triplex was higher by 3 and 15 times than that of BC suggesting
that the alkyl chain remarkably influence the triplex binding.
Complex Formation Stoichiometry (Job plot)
The binding stoichiometry of association of these analogs with
the RNA triplex and the possible number of binding sites were
determined independently by continuous variation analysis (Job
plot) [75,76] in fluorescence. In Job plot, the ligand: RNA molar
ratio was varied while the total molar concentration remains
constant. The stoichiometry of binding is determined by the molar
ratio where maximal binding is observed. The plot of difference
fluorescence intensity (DF) at respective lmax, for BC, BC1 and
BC2, versus their mole fractions presented in Figure S1, revealed a
single binding mode for both these molecules on the RNA-triplex.
From the inflection points x=0.190, 0.186 and 0.178 (indicated
by arrow), the number of nucleotides bound per BC, BC1and BC2
can be estimated to be around 4.26, 4.37 and 4.6, respectively.
This is in good agreement with the number of binding sites
obtained from the non-cooperative McGhee-von Hippel analysis
of the spectrophotometric data (Table 1).
Optical Thermal Denaturation Studies and Analysis of the
Stabilization Effects
A thermal denaturation experiment can determine the stability
of the triplex and duplex structures. Tm is defined as temperature
of melting or, more accurately, as temperature of mid-transition.
Beyond a simple numerical value (the Tm), a thermal denaturation
experiment, that depicts the variation of the absorbance plotted vs.
temperature, yields important thermodynamic information. The
third strand [poly(U)] separation from the triplex occurs at 35uC
while the duplex strand denaturation occurs at 45uC under the
Figure 3. Fluorescence spectra of BC and BC analogs in
presence of triplex. (A) BC (B) BC1 (C) BC2 (2.0 mM each) treated
with increasing concentration of RNA triplex. P/D saturation for BC, BC1
and BC2 were 32.0, 24.0 and 18.0, respectively. Inset: respective non-
cooperative Scatchard plots of binding.
doi:10.1371/journal.pone.0037939.g003
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literature data [32]. The stability of triplex in presence of BC and
the analogs was monitored by UV thermal melting curves that are
presented in Figure 4. It can be seen that the analogs effected
remarkable stabilization of the third strand. The extent of
stabilization was high for BC1 and higher for B2 compared to
BC suggesting a delayed strand separation with bound analogs.
The stabilization temperature for the third strand in presence of
BC, BC1 and BC2 were 17.5, 18.1 and 20.5uC, respectively.
Detailed melting data is presented in Table 2.
Binding Mode of Berberine Analogs from Fluorescence
and Viscosity Studies
Although the above experiments indirectly suggest intercalation
model of interaction, additional experiments aimed at the
elucidation of intercalation mode were performed by fluorescence
energy transfer, quenching, and viscosity studies. Energy transfer
from the base triplets to the bound alkaloid analogs can be used as
an evidence for intercalative binding. Efficient energy transfer
manifested by an increased quantum yield can occur only when
the bound alkaloid molecules are oriented parallel to the base
triplets in an intercalated manner. In Figure 5A the variation of
Ql/Q310 with wavelength for the complexation of BC and analogs
at a D/P (alkaloid/RNA triplex molar ratio) of 1.0 is presented.
An increase in the quantum yield is revealed in the 230–280 nm
region with maximum around 258 nm which is the RNA
absorbing region. The increase in quantum yield was higher for
BC1 and the highest for BC2 compared to BC indicating that the
binding of these molecules results in significant energy transfer to
the base triplets providing clear evidence for a better intercalated
orientation of the analogs compared to BC.
Further support for stronger intercalation of the analogs was
gathered from fluorescence polarization anisotropy experiments.
The polarization of the complexes enhanced as the D/P increased
(Figure 5B) and the values were 0.15, 0.18 and 0.21 confirming the
intercalated binding and the higher binding of BC over BC1 and
BC2.
The mode of binding was subsequently confirmed to be
intercalative from viscosity studies also. Intercalation of molecules
between DNA bases is known to increase the viscosity of the
solution owing to unwinding and elongation of the double helix as
proposed by Lerman [77]. This is due to the fact that intercalation
leads to enhancement of the axial length of the nucleic acid
resulting in more rigidity due to enhancement of the frictional
coefficient. The binding mode of the BC analogs to the RNA
triplex was probed by measuring the viscosity of the triplex
solution in the presence of increasing concentrations of the
alkaloids, and estimating the changes in relative viscosities with
varying D/P ratio. The change was found to be more rapidly
pronounced (not shown) for the analogs compared to berberine
complexes, and the saturation was achieved at a much lower D/P
ratio indicating tighter intercalative binding of the analogs. It is
evident from Figure 5C that the binding of the analogs results in
an increase in the relative viscosity of the solution. Viscosity results
are expressed as length enhancements with respect to a standard
value (b) of 2.0 for a true intercalator resulting in a theoretical
length enhancement of 0.34 nm. The b values for BC1 and BC2
triplex complexes were 1.60, and 1.76, respectively, against a value
of 1.51 for BC. Thus, a better intercalation model may be
Table 1. Binding parameters for poly(U)Npoly(A)*poly(U)
triplex-alkaloid complexation obtained from McGhee-von
Hippel analysis of the Scatchard plot from the
spectrophotometric and fluorimetric titration data at 25uC
a.
Alkaloid Absorbance Fluorescence
Ki /10
5 M
21 n Ki /10
5 M
21 n
BC 2.8860.02 4.3 3.960.05 4.1
BC1 8.6560.34 4.2 9.560.10 4.0
BC2 39.8760.41 4.3 47.060.56 4.3
aAverage of four determinations in each case. Ki is the intrinsic binding constant
to an isolated binding site and ‘n’ represents the number of excluded sites.
doi:10.1371/journal.pone.0037939.t001
Figure 4. Thermal melting profiles of triplex with BC and BC
analogs. Poly(U)Npoly(A)*poly(U) (30.0 mM) treated with (A) BC (B) BC1
and (C) BC2. Curves 1–6 represent D/P in the range 0–0.6.
doi:10.1371/journal.pone.0037939.g004
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intercalation may be assigned to the binding of BC. Although BC
and analogs have partial saturation in the ring structure resulting
in buckled structure a better intercalation appears to be feasible
with the analogs contributed by the anchoring of the side chain
and the above described experiments unequivocally confirm a
better intercalation geometry for the analogs compared to BC.
Additionally, fluorescence quenching experiments [78] which is
also a reliable method for studying the binding mode of small
molecules to nucleic acids were performed to lend support to the
intercalation mode. Generally, the molecules bound to the surface
of the triplex by electrostatic interaction will be easily accessible to
a quencher while those bound inside the helix will be protected
from the quencher [78,79]. It is known that anionic quenchers like
[Fe(CN)6]
42 cannot access the inside of the helix due to the strong
electrostatic repulsion from the negatively charged phosphate
groups and consequently very little quenching will be observed for
fluorescent small molecules bound in the interior of the triplex.
Consequently, the magnitude of the Stern-Volmer quenching
constant (Ksv) of ligands that are bound inside by intercalation will
be lower than that of the free molecules. In Figure S2, the data on
the fluorescence quenching of the berberine analogs in presence of
K4[Fe(CN)6] is presented. Ksv values of free BC1 and BC2 with
[Fe(CN)6]
42 were 217 M
21, respectively, while that of bound ones
were 73.0 and 42.0 M
21, respectively, indicating that the bound
berberine analogs are considerably protected and sequestered
away from the solvent. This result further suggests an intercalative
or similar kind of binding for the analogs inside the triplex.
Determination of Quantum Efficiency
The quantum efficiency (Q) ligand of a binding to nucleic acid is
a measure of the energy transferred from to the ligand upon
complexation. This is obtained from the ratio of the quantum
efficiency of ligand complexed to nucleic acid (qb) to the quantum
efficiency of the free ligand (qf). Quantum efficiency values are
important information that may support the strong binding of the
analogs to the RNA triplex. A plot of DA against the inverse of
RNA triplex concentration gave an exponential plot (not shown)
from which quantum efficiency values of 60.0, 44.9 and 22.8,
respectively, for BC, BC1, and BC2 have been determined. Since
Qi s.1.0 this indicates enhancement of fluorescence intensity and
greater retention of fluorescence energy by the bound alkaloid due
to shielding within the binding site from quenching by solvent.
Conformational Aspects of the Binding
Conformational changes associated with the binding of these
analogs in comparison to berberine were studied from circular
dichroism studies. The circular dichroic spectrum of the triplex
was characterized by a positive band around 270 nm followed by a
small negative band around 240 nm. (Curve 1, Figure 6A). The
spectrum is in conformity with the literature report. In the
presence of BC an enhancement and red shift of the positive band
and a small change in the ellipticity of the negative band occurs. A
small induced CD band is developed in the 320–360 nm with a
maximum around 345 nm. In the presence of BC1, the positive
ellipticity of the triplex decreased with a concomitant red shift of
the maximum (Figure 6B). There was a small decrease of the
negative band maximum around 240 nm. The overall changes in
the CD spectrum were more pronounced compared to the
changes with BC. An induced CD band appeared in the 320–
360 nm, but was of an excision split type with a negative and
positive ellipticity around 340 and 365 nms. For the binding of
BC2, the intrinsic CD band ellipticity of the triplex around
270 nm decreased significantly with a concomitant red shift of the
peak maximum (Figure 6C). The 240 nm band ellipticity also
reduced in intensity. The appearance of the induced CD bands
was similar to that with BC1, but the intensity was more
pronounced. From the comparative CD curves it is clear that
the binding induced CD perturbation of the triplex structure was
highest with BC2 and followed the order BC2.BC1.BC.
Furthermore, the pronounced induced CD band and the
differences in their appearance indicate the analogs bind strongly
Table 2. Effect of alkaloids on the thermal stability of the poly(U)Npoly(A)*poly(U) triplex
a.
Complex D/P Tm’/(6C) 3 R 2 Tm’’/(6C) 2 R 1 DTm’/(6C) 3 R 2 DTm’’/(6C) 2 R 1
Triplex alone 0 37.0 47.5 – –
Triplex + BC 0.1 42.0 48.0 5.0 0.5
0.2 46.8 – 9.7 –
0.4 50.1 – 13.1 –
0.5 52.9 – 15.9 –
0.6 54.5 – 17.5 –
Triplex +BC1 0.1 42.2 48.3 5.2 0.8
0.2 48.0 – 11.0 –
0.4 50.6 – 13.6 –
0.5 53.1 – 16.1 –
0.6 55.1 – 18.1 –
Triplex + BC2 0.1 44.0 50.0 7.0 2.5
0.2 49.6 – 12.6 –
0.4 41.0 – 14.0 –
0.5 54.3 – 17.3 –
0.6 57.5 – 20.5 –
aAverage from three experiments. Error limits for individual Tm measurements are estimated to be within 60.5uCi n .Tm’ (3 R 2) and Tm’’ (2R1) are triplex to duplex and
duplex to single stranded transitions respectively. DTm =( Tm of triplex-alkaloid complex – Tm of triplex or duplex).
doi:10.1371/journal.pone.0037939.t002
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affinity of the latter. It also appears that the bound orientation of
BC analogs on the triplex structure is significantly different from
that of BC as revealed by different induced CD patterns that
reflects the interaction of the transition moments of the bound
molecule and the base triplets.
Figure 5. Variation of the relative fluorescence quantum yields,
anisotropy and visocisty. (A) Variation of the relative fluorescence
quantum yield of BC (&), BC1 (N), and BC2 (m) in the presence of
poly(U)N.poly(A)*poly(U) as a function of excitation wavelength. (B) A
plot of the variation of anisotropy values versus P/D ratio for the
complexation of BC (&), BC1 (N), BC2 (m) with poly(U)Npoly(A)*poly(U).
(C) A plot of increase in helix contour length (L/Lo) versus r for the
complexation of BC (&), BC1 (N), BC2 (m) with poly(U)Npoly(A)*poly(U)
at 2560.5uC.
doi:10.1371/journal.pone.0037939.g005
Figure 6. Circular dichroic spectral titration of triplex with BC
and BC analogs. Titration data of poly(U)Npoly(A)*poly(U) (30 mM)
treated with (A) 0.0, 3.0, 6.0, 9.0, 12.0, 18.0 mM of BC (B) 0.0, 3.0, 6.0, 9.0,
12.0, 15.0, 18.0, 24.0 mM of BC1 and (C) 0.0, 3.0, 6.0, 9.0, 12.0, 15.0, 18.0,
24.0 mM of BC2. Inset: A magnified representation of the induced CD
spectra in the region 300–400 nm.
doi:10.1371/journal.pone.0037939.g006
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Calorimetry
Thermodynamic characterization of the binding was performed
from isothermal titration calorimetry. The calorimetric profiles for
the binding of BC1 and BC2 to the RNA triplex are presented in
Figure 7. Binding in each case was characterized by the presence of
exothermic peaks that followed each injection of the alkaloid to the
triplex solution. Fits of the integrated heat data were carried out
using a model of single set of identical sites that yielded a fairly good
fitting of the experimental data. The thermodynamic parameters
elucidated for the binding of the alkaloids to the triplex are collated
inTable3.TheITCdataforthebindingofBCtothetriplexyielded
an association constant of (1.5060.04610
5
M
21). This is in close
agreement to the value reported previously [32]. The binding of
BC1 yielded a six times higher association constant of
(9.7360.09610
5
M
21) while the binding of BC2 was remarkably
stronger compared to BC and BC1 with a Ka value of
(2.3060.1610
6
M
21) showing almost fifteen times stronger binding
than BC. The affinity values are in excellent agreement with the
values from spectroscopic results. The number of binding sites
obtained from ITC as reciprocal of stoichiometry were closely
comparabletothenumberofexcludedsitesfromspectroscopicdata
and also the stoichiometry data from Job plot. The Gibbs energy
change (DG
o) was found to ,27.1 kcal/mol for BC but higher at
28.22 kcal/mol for BC1 and 8.73 kcal/mol for BC2 showing the
spontaneity of the interaction in all cases in general and more for
BC1 and BC2. The binding of BC to triplex was predominantly
enthalpy driven with a small favorable entropy change as reported
previously[32].Ontheotherhand,bindingofBC1tothetriplexwas
driven by a large positive entropy change (5.92 kcal/mol) and a
smallenthalpychange.ItmayberecalledthatCDspectroscopyhad
indicated remarkable conformational changes of triplex on binding
of BC1 and BC2 compared to BC. The overall entropychange may
be expected from this conformational change. Binding of BC1 and
BC2 has been revealed to result in stronger intercalation complex
compared to BC and consequently a larger lengthening, stiffening,
and rigidifying of the triplex may be the most likely explanation for
the entropic cost as suggested by Chaires [80]. This was also
confirmed from our viscosity studies where the length enhancement
ofthetriplexduetounwindingwithBC1andBC2wasmuchhigher
than with BC.
In conclusion, we report here a remarkably higher binding
affinity of two new 9-substituted berberine analogs to the RNA
triplex of poly(U).poly(A)*poly(U). This has also been comple-
mented by higher melting stabilization of the third stand, stronger
conformational changes of the triplex structure and generation of
stronger induced CD bands for the triplex bound analogs. The
overall higher affinity and stabilization by the analogs were clearly
reflected in the thermodynamic parameters of the complexation
Figure 7. Representative isothermal titration calorimetry profiles for the titration of BC and analogs to triplex. Titration profiles are
shown for poly(U)Npoly(A)*poly(U) with (A) BC (B) BC1 and (C) BC2 at 25uC. The top panels represent raw data for the sequential injection of the
alkaloid into the triplex solution. The lower panels represent the corresponding normalized heat signals versus molar ratio. The data points (&) reflect
the experimental injection heat while the solid lines represent the calculated fit of the data.
doi:10.1371/journal.pone.0037939.g007
Table 3. ITC Derived Thermodynamic parameters for the
binding of BC, BC1 and BC2 with poly(U)Npoly(A)*poly(U)
triplex at 25uC.
a
Parameters BC BC1 BC2
Ka /10
5
M
21 1.560.04 9.7360.09 2360.10
N 4.7 4.5 4.5
DG
o (kcal mol
21) 27.1060.02 28.2260.04 28.7360.05
DH
o (kcal mol
21) 24.8660.03 22.3060.05 21.6560.05
TDS
o (kcal mol
21) 2.24 5.92 7.08
aAll the data in this table are derived from ITC experiments and are average of
four determinations. Ka and DH
o values were determined from ITC profiles
fitting to Origin 7 software as described in the text. n is the site size which is the
reciprocal of the stoichiometry N. The values of DG
o and TDS
o were determined
using the equations DG
o = 2 RTln Ka and DG
o =DH
o 2 TDS
o. All the ITC
profiles were fit to a model of single binding site.
doi:10.1371/journal.pone.0037939.t003
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alkyl side chain clearly influence in the triplex stabilization
phenomena of BC analogs. These results may be useful for
formulating effective antigene strategies involving new berberine
derivatives and the RNA triplex.
Supporting Information
Figure S1 Job plot for the complexation of BC, BC1 and
BC2 with the RNA triplex.
(TIF)
Figure S2 Stern-Volmer plots for the quenching of BC,
BC1 and BC2 by RNA triplex.
(TIF)
Table S1 Optical properties of free and triplex bound
alkaloid analogs.
(DOC)
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